| __timestamp | Alkermes plc | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 447875000 | 56369000000 |
| Thursday, January 1, 2015 | 483393000 | 62786000000 |
| Friday, January 1, 2016 | 519270000 | 62427000000 |
| Sunday, January 1, 2017 | 567637000 | 62453000000 |
| Monday, January 1, 2018 | 601826000 | 65724000000 |
| Tuesday, January 1, 2019 | 693218000 | 70421000000 |
| Wednesday, January 1, 2020 | 572904000 | 80591000000 |
| Friday, January 1, 2021 | 603913000 | 86645000000 |
| Saturday, January 1, 2022 | 218108000 | 100551000000 |
| Sunday, January 1, 2023 | 253037000 | 42907000000 |
| Monday, January 1, 2024 | 245331000 | 115557000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for strategic planning. This analysis delves into the cost of revenue for Dr. Reddy's Laboratories Limited and Alkermes plc from 2014 to 2023. Over this period, Dr. Reddy's Laboratories consistently reported higher costs, peaking in 2024 with a staggering 115% increase from 2014. In contrast, Alkermes plc experienced a more volatile trend, with a notable dip in 2022, reflecting a 54% decrease from its 2019 peak. This fluctuation could indicate strategic shifts or market challenges. The data highlights the importance of cost management in maintaining competitive advantage. Missing data for Alkermes in 2024 suggests potential reporting delays or strategic changes. As the pharmaceutical landscape continues to shift, these insights provide a window into the financial strategies of two key players.
Novo Nordisk A/S vs Alkermes plc: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Merck & Co., Inc. and Alkermes plc's Expenses
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Alkermes plc
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.'s Expenses
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Iovance Biotherapeutics, Inc.
Comparing Cost of Revenue Efficiency: Exelixis, Inc. vs Alkermes plc
Alkermes plc vs Veracyte, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Alkermes plc and BioCryst Pharmaceuticals, Inc.'s Expenses